NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered peptides from Peptide Pole Hongkong? Mail in a sample (US only) and let us test it.

Test my supply
+10 more ↓
71%
Finnrick rating
#290 of 500 ranked vendors
28 of 34 classifiable tests passed
methodology · Purity focus
Finnrick analysis

Peptide Pole Hongkong shows its strongest purity-focused evidence in GHK-Cu, Tirzepatide, and Retatrutide, with recent high-purity results but some fill, label, endotoxin, and identity caveats. The catalog is dispersed rather than uniform: KLOW and BPC-157 break late on identity, while Tesamorelin remains mixed across batches.

methodology →
vendor intelligence report
Vendor Intelligence Report: Peptide Pole Hongkong

Hong Kong registry checks and a recent web footprint complicate PPHK's claimed Co. Ltd identity. The report maps vendor-managed forum promotion, impersonator exposure, unverified COA claims, and payment-channel recourse without a blanket verdict.

22 pages6 risk factors assessed2 Jul 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
88%
4
2
Retatrutide
$0.72
84%
15
3
Tirzepatide
$0.41
83%
5
4
KLOW
$0.23
74%
5
5
Tesamorelin
$2.00
51%
5
6
BPC-157
$0.70
48%
3
7
Cagrilintide
$1.70
-
0
8
CJC-IPA
$1.10
-
0
9
Glutathione
$0.01
-
0
10
hCG
-
-
0
11
HGH
$0.42
-
0
12
Ipamorelin
$0.65
-
0
13
KPV
$0.60
-
0
14
MOTS-c
$0.46
-
0
15
PT-141
$0.60
-
0
16
Selank
-
-
0
17
Semax
-
-
0
18
TB-500
$0.50
-
0
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%4 Feb 2026: 78%4 Feb 2026: 79%8 May 2026: 81%2 Jun 2026: 81%8 Jun 2026: 79%16 Jun 2026: 83%16 Jun 2026: 83%16 Jun 2026: 83%24 Jun 2026: 83%26 Jun 2026: 74%26 Jun 2026: 74%10 Jul 2026: 74%20 Jul 2026: 68%20 Jul 2026: 68%20 Jul 2026: 69%30 Jul 2026: 69%30 Jul 2026: 70%30 Jul 2026: 70%3 Aug 2026: 68%3 Aug 2026: 68%4 Aug 2026: 69%4 Aug 2026: 69%5 Aug 2026: 70%6 Aug 2026: 70%12 Aug 2026: 70%9 Sep 2026: 71%14 Sep 2026: 71%25 Sep 2026: 72%29 Oct 2026: 73%29 Oct 2026: 73%2 Nov 2026: 73%2 Nov 2026: 73%6 Nov 2026: 73%9 Nov 2026: 72%17 Nov 2026: current 71%78%81%71%Feb 26Nov 26
Peptide testing

Ordered peptides from Peptide Pole Hongkong? Mail in a sample (US only) and let us test it.

Test my supply
Peptide Pole Hongkong test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
9 Nov 2026
Fail
KLOW
lab nameView COA
6 Nov 2026
Pass
Retatrutide
lab nameView COA
2 Nov 2026
Fail
BPC-157
lab nameView COA
2 Nov 2026
Fail
Tesamorelin
lab nameView COA
29 Oct 2026
Pass
Tesamorelin
lab nameView COA
29 Oct 2026
Pass
Tirzepatide
lab nameView COA
25 Sep 2026
Pass
KLOW
lab nameView COA
14 Sep 2026
Pass
Retatrutide
lab nameView COA
9 Sep 2026
Pass
KLOW
lab nameView COA
12 Aug 2026
Pass
Tirzepatide
lab nameView COA
1-10 of 37

About Peptide Pole Hongkong test results from Finnrick

Peptide Pole Hongkong is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 6 peptides and 37 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Peptide Pole Hongkong peptides in this dataset are BPC-157 (3 tests), GHK-Cu (4 tests) and KLOW (5 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 37 recent tests.

Corrections
No corrections.
Peptide testing

Ordered peptides from Peptide Pole Hongkong? Mail in a sample (US only) and let us test it.

Test my supply